Schedule 13G ownership disclosure

ERNEXA THERAPEUTICS INC

Common Stock, par value $0.005 per share · CUSIP: 114082308

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Shameek Konar

    Shares: 558,531.00 · Class: 7.12%

  • Victoria Konar

    Shares: 558,531.00 · Class: 7.12%

  • Regolith Capital Investments LP

    Shares: 547,668.00 · Class: 6.98%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-121683
Form type
SCHEDULE 13G/A
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Dec 16, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub